- Termination of Registration of a Class of Security under Section 12(g) (15-12G)
March 30 2012 - 12:17PM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS
13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number
000-23544
HUMAN PHEROMONE SCIENCES, INC.
(Exact name of registrant as specified in
its charter)
California
|
|
94-3107202
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
|
84 West Santa Clara Street, San Jose, California
|
|
95113
|
(Address of principal executive offices)
|
|
(Zip code)
|
Registrant’s telephone
number:
(408) 938-3030
Common Stock
(Title of each class of securities covered
by this Form)
(Titles of all other classes of securities
for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate
the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)
|
¨
|
Rule 12g-4(a)(2)
|
¨
|
Rule 12h-3(b)(1)(i)
|
¨
|
Rule 12h-3(b)(1)(ii)
|
x
|
Rule 15d-6
|
¨
|
Approximate number of holders
of record as of the certification or notice date:
487
Pursuant to the requirements of the Securities
Exchange Act of 1934
(Name of registrant as specified in charter)
has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: March 30,
2012
|
/s
/ William P. Horgan
|
|
William P. Horgan
|
|
Chairman and Chief Executive Officer
|
|
(Principal Executive Officer)
|
Human Pheromone Sciences (GM) (USOTC:EROX)
Historical Stock Chart
From May 2024 to Jun 2024
Human Pheromone Sciences (GM) (USOTC:EROX)
Historical Stock Chart
From Jun 2023 to Jun 2024